GWAS analysis of patients with AAV shows that its pathogenesis has genetic component, distinguishing GPA from MPA as well as implying that PR3-AAV and MPO-AAV are distinct autoimmune syndromes, independent of the characteristics of the clinical phenotype (11). This evidence concerns the gene PRTN3 and microscopic polyangiitis.